OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies
Michael A. Thompson, Sigrun Hallmeyer, Veronica Fitzpatrick, et al.
Journal of patient-centered research and reviews (2022) Vol. 9, Iss. 3, pp. 149-157
Open Access | Times Cited: 11
Michael A. Thompson, Sigrun Hallmeyer, Veronica Fitzpatrick, et al.
Journal of patient-centered research and reviews (2022) Vol. 9, Iss. 3, pp. 149-157
Open Access | Times Cited: 11
Showing 11 citing articles:
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 7, pp. 1419-1438
Open Access | Times Cited: 6
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 7, pp. 1419-1438
Open Access | Times Cited: 6
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
SARS-CoV-2 primary and breakthrough infections in patients with cancer: Implications for patient care
Lindsey Wang, William Wang, Rong Xu, et al.
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101384-101384
Open Access | Times Cited: 9
Lindsey Wang, William Wang, Rong Xu, et al.
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101384-101384
Open Access | Times Cited: 9
Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis
Hamid Harandi, Parisa Fallahtafti, Amirali Karimi, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Hamid Harandi, Parisa Fallahtafti, Amirali Karimi, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing
Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al.
Biology Methods and Protocols (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al.
Biology Methods and Protocols (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Risk factors for COVID-19 pneumonia in patients with hematological malignancies: a multi-center, prospective study in China
Jun Li, Ran Chen, Lin Cao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jun Li, Ran Chen, Lin Cao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-Analysis Using GRADE
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
S Kavikondala, Katrin Haeussler, Xuan Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies
Chien-Tzu Huang, Ching-Ping Lee, Tzu‐Yin Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5647-5647
Open Access
Chien-Tzu Huang, Ching-Ping Lee, Tzu‐Yin Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5647-5647
Open Access
Characteristics of Patients with Hematologic Malignancies Without Seroconversion Post-COVID19 Third Vaccine Dosing
Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
